Trial Profile
Single escalating dose trial of anivamersen-pegnivacogin [REG2] in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2014
Price :
$35
*
At a glance
- Drugs Anivamersen-pegnivacogin (Primary)
- Indications Venous thrombosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Regado Biosciences
- 19 Feb 2014 New trial record